Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in Argentina
2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Enrolling by invitationOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
- Where
- Buenos Aires
- Age
- 18 years to 85 years
- People
- 900 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00 - No phaseTaking peopleInstitutional Registry of Rare Diseases
- Where
- Buenos Aires
- People
- 380
- Run by
- Hospital Italiano de Buenos Aires
See details and how to joinNCT06573723